Molecular Mechanisms of Antiviral Agents against Dengue Virus

QR Code

Molecular Mechanisms of Antiviral Agents against Dengue Virus

Dengue is a major global health threat causing 390 million dengue infections and 25,000 deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of a clinically approved antiviral against dengue virus (DENV) drive the urgent demand for the development of novel anti-DEN...

Full description

Bibliographic Details
Main Authors:	Lee, Michelle Felicia, Wu, Yuan Seng, Poh, Chit Laa *
Format:	Article
Language:	English
Published:	MDPI 2023
Subjects:	RA Public aspects of medicine
Online Access:	http://eprints.sunway.edu.my/2156/ http://eprints.sunway.edu.my/2156/1/molecular%20mechanisms%20of%20antiviral%20agents%20against%20dengue%20virus.pdf

Similar Items

Antiviral peptides against dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

Development of novel antiviral peptides against dengue serotypes 1-4
by: Lee, Michelle Felicia, et al.
Published: (2023)

Innate and adaptive immune evasion by dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

Structure-based design of antivirals against Envelope Glycoprotein of dengue virus
by: Anasir, M. I. *, et al.
Published: (2020)

The conserved molecular determinants of virulence in dengue virus
by: Zuleeza A,, et al.
Published: (2019)

Peptides as therapeutic agents for dengue virus
by: Chew, Miaw Fang *, et al.
Published: (2017)

Evaluation for antiviral potential of ficus deltoidea against dengue virus type-2
by: Yuan, Seng Wu, et al.
Published: (2024)

Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)

Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)

Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)

Role of microRNAs in antiviral responses to dengue infection
by: Wong, Rui Rui, et al.
Published: (2020)

Cloning and expression of prM and it's use to distinguish host immune responses against dengue virus and Japanese encephalitis virus infections
by: Wang, Seok Mui
Published: (2001)

Development of dengue vaccines
by: Lim, Chee Siean *, et al.
Published: (2018)

Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Lalani, S.*, et al.
Published: (2020)

Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)

Birdcages source of dengue virus
by: Medical, Xpress
Published: (2016)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz, Al-Fattah Yahaya *, et al.
Published: (2023)

Antiviral activity of traditional Chinese medicinal plants Dryopteris crassirhizoma and Morus alba against dengue virus
by: Maryam, Maqsood, et al.
Published: (2020)

Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting
by: Lim, Hui Xuan *, et al.
Published: (2022)

In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
by: Pourianfar, Hamid Reza, et al.
Published: (2012)

In silico analysis for discovery of dengue virus inhibitor from natural compounds
by: Roney, Miah, et al.
Published: (2022)

Development of single chain variable fragment antibodies against dengue virus
by: Leong, Yee Wei.
Published: (2006)

Antiviral activity of resveratrol against human and animal viruses
by: Abba, Yusuf, et al.
Published: (2015)

Strategies to improve the physicochemical properties of peptide‑based drugs
by: Lee, Michelle Felicia *, et al.
Published: (2023)

Antiviral effect and mechanism of action of novel N-substituted 5-(phenylamino)uracil derivatives against dengue and chikungunya viruses / Noor Fahitah Abu Hanipah
by: Abu Hanipah, Noor Fahitah
Published: (2020)

In-silico design of curcumin analogs as potential inhibitors of dengue virus NS2B/NS3 protease
by: Roney, Miah, et al.
Published: (2023)

Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
by: Lim, Hui Xuan *, et al.
Published: (2021)

Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)

Exploring bioflavonoids as novel antivirals against Chikungunya virus / Rafidah Lani
by: Rafidah, Lani
Published: (2016)

Antiviral Nanomedicine-based approaches against Epstein-Barr virus infection
by: Abdelmonem, Mohamed, et al.
Published: (2024)

Predictors for early detection of severe Dengue with shock / Quah Chai Hoong
by: Quah, Chai Hoong
Published: (2019)

Development of peptide vaccines in dengue
by: Reginald, Kavita*, et al.
Published: (2017)

Molecular docking analysis of Carica papaya Linn constituents as antiviral agent
by: Narayanaswamy, Radhakrishnan, et al.
Published: (2017)

Assessing the efficacy and probable molecular mechanism of oncolytic measles virus-induced cell death in cultured nasopharyngeal carcinoma cells
by: Looi, Hong Keat
Published: (2024)

The Predictive And Diagnostic Accuracy Of Pentraxin-3 And Vascular Endothelial Growth Factor In Severe Dengue
by: Low, Gary Kim Kuan
Published: (2019)

Antiviral activity of Cymbopogon nardus methanol fractions against measles disease virus
by: Reagan Entigu, ak Linton @ Jerah
Published: (2014)

Circular RNA TFO as antiviral therapy against feline infectious peritonitis virus
by: Choong, Oi Kuan, et al.
Published: (2012)

Pharmacophore-based molecular docking of usnic acid derivatives to discover anti-viral drugs against influenza A virus
by: Roney, Miah, et al.
Published: (2023)

Computational studies demonstrating dithymoquinone of Nigella sativa as a potential anti-dengue agent: Short review
by: Roney, Miah, et al.
Published: (2024)

Computational evaluation of quinones of Nigella sativa L. as potential inhibitor of dengue virus NS5
by: Roney, Miah, et al.
Published: (2023)